Formation of amyloid fibrils from β-amylase

FEBS Letters

Volumn 586, Issue 6, 2012, Pages 680-685

  Luo, Jian Chau ^a   Wang, Shing Chuen ^a   Jian, Wei Bang ^a   Chen, Chien Hsing ^a   Tang, Jaw Luen ^a   Lee, Cheng I ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Amylase; Amyloid fibril; Congo red birefringence; Prion; TEM

Indexed keywords

AMYLOID; BETA AMYLASE; PRION PROTEIN;

ALPHA HELIX; ARTICLE; BETA SHEET; CONTROLLED STUDY; ENZYME STRUCTURE; FIBER; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE;

AMYLOID; ANIMALS; BETA-AMYLASE; CIRCULAR DICHROISM; ENZYME STABILITY; HUMANS; PRION DISEASES; PRIONS; PROTEIN STRUCTURE, SECONDARY;

EID: 84862811627     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.01.062     Document Type: Article

References (30)

1. Kelly, J.W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struc. Biol. 8, 101-106.
2. Sunde, M. and Blake, C. (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50, 123-159. (Pubitemid 27449487)
3. Coelho, T. (1996) Familial amyloid polyneuropathy: new developments in genetics and treatment. Curr. Opin. Neurol. 9, 355-359.
4. Makarava, N., Lee, C.I., Ostapchenko, V.G., et al. (2007) Highly promiscuous nature of prion polymerization. J. Biol. Chem. 282, 36704-36713.
5. Legname, G., Baskakov, I.V., Nguyen, H.O., et al. (2004) Synthetic mammalian prions. Science 305, 673-676. (Pubitemid 39006757)
6. Riek, R., Hornemann, S., Wider, G., et al. (1996) NMR structure of the mouse prion protein domain PrP(121-231). Nature 382, 180-182. (Pubitemid 26242887)
7. James, T.L., Liu, H., Ulyanov, N.B., et al. (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94, 10086-10091.
8. Donne, D.G., Viles, J.H., Groth, D., et al. (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. USA 94, 13452-13457.
9. Booth, D.R., Sunde, M., Bellotti, V., et al. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787-793. (Pubitemid 27106061)
10. Guijarro, J.I., Sunde, M., Jones, J.A., et al. (1998) Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. USA 95, 4224-4228. (Pubitemid 28207893)
11. Chiti, F., Webster, P., Taddei, N., et al. (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. USA 96, 3590-3594. (Pubitemid 29168954)
12. Rejzek, M., Stevenson, C.E., Southard, A.M., et al. (2011) Chemical genetics and cereal starch metabolism: structural basis of the non-covalent and covalent inhibition of barley beta-amylase. Mol. Biosyst. 7, 718-730.
13. Bocharova, O.V., Breydo, L., Parfenov, A.S., et al. (2005) In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J. Mol. Biol. 346, 645-659.
14. Nilsson, M.R. (2004) Techniques to study amyloid fibril formation in vitro. Methods 34, 151-160.
15. Klunk, W.E., Jacob, R.F. and Mason, R.P. (1999) Quantifying amyloid by congo red spectral shift assay. Methods Enzymol. 309, 285-305. (Pubitemid 29446456)
16. Gertz, M.A. (2004) The classification and typing of amyloid deposits. Am. J. Clin. Pathol. 121, 787-789.
17. Baskakov, I.V., Legname, G., Gryczynski, Z., et al. (2004) The peculiar nature of unfolding of the human prion protein. Protein Sci. 13, 586-595. (Pubitemid 38252555)
18. Chen, A.K.H., Lin, R.Y.Y., Hsieh, E.Z.J., et al. (2010) Induction of amyloid fibrils by the C-Terminal fragments of TDP-43 in amyotrophic lateral sclerosis. J. Am. Chem. Soc. 132, 1186-1187.
19. Diamond, R. (1974) Real-space refinement of the structure of hen egg-white lysozyme. J. Mol. Biol. 82, 371-391.
20. Gray, T.M. and Matthews, B.W. (1987) Structural analysis of the temperaturesensitive mutant of bacteriophage T4 lysozyme, glycine 156--aspartic acid. J. Biol. Chem. 262, 16858-16864.
21. Prusiner, S.B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383.
22. Tateishi, J., Brown, P., Kitamoto, T., et al. (1995) First experimental transmission of fatal familial insomnia. Nature 376, 434-435.
23. Hayward, P.A., Bell, J.E. and Ironside, J.W. (1994) Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 20, 375-383. (Pubitemid 24246063)
24. Winklhofer, K.F., Tatzelt, J. and Haass, C. (2008) The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J. 27, 336-349. (Pubitemid 351161650)
25. Resenberger, U.K., Harmeier, A., Woerner, A.C., et al. (2011) The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J. 30, 2057-2070.
26. Silveira, J.R., Raymond, G.J., Hughson, A.G., et al. (2005) The most infectious prion protein particles. Nature 437, 257-261. (Pubitemid 41294488)
27. Walsh, D.M., Klyubin, I., Fadeeva, J.V., et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. (Pubitemid 34288854)
28. Kayed, R., Head, E., Thompson, J.L., et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. (Pubitemid 36444329)
29. Bucciantini, M., Giannoni, E., Chiti, F., et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511. (Pubitemid 34288846)
30. Whalen, B.M., Selkoe, D.J. and Hartley, D.M. (2005) Small non-fibrillar assemblies of amyloid beta-protein bearing the Arctic mutation induce rapid neuritic degeneration. Neurobiol. Dis. 20, 254-266. (Pubitemid 41476253)